Management of Patients with Locally Advanced Breast Cancer

Surgical Clinics of North America

Volumn 87, Issue 2, 2007, Pages 379-398

  Lee, Marie Catherine ^a   Newman, Lisa A ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GEMCITABINE; LETROZOLE; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; MOLECULAR MARKER; NAVELBINE; PACLITAXEL; TAMOXIFEN; THIOTEPA; TRASTUZUMAB; VINCRISTINE; VINDESINE;

ADVANCED CANCER; BREAST CANCER; BREAST METASTASIS; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LYMPHADENOPATHY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PATIENT MONITORING; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAMMAPLASTY; MASTECTOMY; MASTECTOMY, SEGMENTAL; NEOADJUVANT THERAPY; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 34248232646     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2007.01.012     Document Type: Review

References (85)

1. Olivotto I.A., Chua B., Allan S.J., et al. Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. J Clin Oncol 21 (2003) 851-854
2. Brito R.A., Valero V., Buzdar A.U., et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 19 (2001) 628-633
3. Singletary S.E., Allred C., Ashley P., et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20 (2002) 3628-3636
4. National Cancer Data Base, 1998-2004. Available at: http://web.facs.org/ncdbbmr/ncdbbenchmarks8.cfm. Accessed March 1, 2007.
5. Haagensen C., and Stout A. Carcinoma of the breast II. Criteria of operability. Ann Surg 118 (1943) 859
6. Harris J.R., Sawicka J., Gelman R., et al. Management of locally advanced carcinoma of the breast by primary radiation therapy. Int J Radiat Oncol Biol Phys 9 (1983) 345-349
7. Rao D.V., Bedwinek J., Perez C., et al. Prognostic indicators in stage III and localized stage IV breast cancer. Cancer 50 (1982) 2037-2043
8. Rubens R.D., Armitage P., Winter P.J., et al. Prognosis in inoperable stage III carcinoma of the breast. Eur J Cancer 13 (1977) 805-811
9. Townsend Jr. C.M., Abston S., and Fish J.C. Surgical adjuvant treatment of locally advanced breast cancer. Ann Surg 201 (1985) 604-610
10. Arnold D.J., and Lesnick G.J. Survival following mastectomy for stage III breast cancer. Am J Surg 137 (1979) 362-366
11. Montague E.D., and Fletcher G.H. Local regional effectiveness of surgery and radiation therapy in the treatment of breast cancer. Cancer 55 (1985) 2266-2272
12. Broadwater J.R., Edwards M.J., Kuglen C., et al. Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity. Ann Surg 213 (1991) 126-129
13. Danforth Jr. D.N., Lippman M.E., McDonald H., et al. Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer. Am Surg 56 (1990) 6-11
14. McCready D.R., Hortobagyi G.N., Kau S.W., et al. The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg 124 (1989) 21-25
15. De Lena M., Varini M., Zucali R., et al. Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery. Cancer Clin Trials 4 (1981) 229-236
16. Perloff M., Lesnick G.J., Korzun A., et al. Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. J Clin Oncol 6 (1988) 261-269
17. Papaioannou A., Lissaios B., Vasilaros S., et al. Pre- and postoperative chemoendocrine treatment with or without postoperative radiotherapy for locally advanced breast cancer. Cancer 51 (1983) 1284-1290
18. Hortobagyi G.N., Ames F.C., Buzdar A.U., et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 62 (1988) 2507-2516
19. Lippman M.E., Sorace R.A., Bagley C.S., et al. Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. NCI Monogr (1986) 153-159
20. Valagussa P., Zambetti M., Bignami P., et al. T3b-T4 breast cancer: factors affecting results in combined modality treatments. Clin Exp Metastasis 1 (1983) 191-202
21. Olson J.E., Neuberg D., Pandya K.J., et al. The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer 79 (1997) 1138-1149
22. Cance W.G., Carey L.A., Calvo B.F., et al. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg 236 (2002) 295-302 [discussion: 3]
23. Mauriac L., Durand M., Avril A., et al. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. Ann Oncol 2 (1991) 347-354
24. Mauriac L., MacGrogan G., Avril A., et al. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS). Ann Oncol 10 (1999) 47-52
25. Schwartz G.F., Birchansky C.A., Komarnicky L.T., et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 73 (1994) 362-369
26. Schwartz G.F., Lange A.K., and Topham A.K. Breast conservation following induction chemotherapy for locally advanced carcinoma of the breast (stages IIB and III). A surgical perspective. Surg Oncol Clin N Am 4 (1995) 657-669
27. Powles T.J., Hickish T.F., Makris A., et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 13 (1995) 547-552
28. Makris A., Powles T.J., Ashley S.E., et al. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 9 (1998) 1179-1184
29. Fisher B., Brown A., Mamounas E., et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15 (1997) 2483-2493
30. Wolmark N., Wang J., Mamounas E., et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr (2001) 96-102
31. Newman L.A., Buzdar A.U., Singletary S.E., et al. A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast conservation therapy feasibility. Ann Surg Oncol 9 (2002) 228-234
32. Bedrosian I., Bedi D., Kuerer H.M., et al. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 10 (2003) 1025-1030
33. Krishnamurthy S., Sneige N., Bedi D.G., et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 95 (2002) 982-988
34. Newman L.A., Kuerer H.M., Fornage B., et al. Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer. Am J Surg 181 (2001) 313-318
35. Samant R., and Ganguly P. Staging investigations in patients with breast cancer: the role of bone scans and liver imaging. Arch Surg 134 (1999) 551-553 [discussion: 4]
36. Khan S.A., Stewart A.K., and Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer?. Surgery 132 (2002) 620-627
37. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16 (1998) 2672-2685
38. Kuerer H.M., Newman L.A., Smith T.L., et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17 (1999) 460-469
39. Singletary S.E., McNeese M.D., and Hortobagyi G.N. Feasibility of breast conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 69 (1992) 2849-2852
40. Scholl S.M., Fourquet A., Asselain B., et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast-conserving surgery: preliminary results of a randomised trial: S6. Eur J Cancer 30A (1994) 645-652
41. Scholl S.M., Pierga J.Y., Asselain B., et al. Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. Eur J Cancer 31A (1995) 1969-1975
42. Recht A., Edge S.B., Solin L.J., et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (2001) 1539-1569
43. Mamounas E. Preliminary results of the NSABP B-27 Trial. Presented at the San Antonio Breast Cancer Symposium 2001. San Antonio (TX), December 2001.
44. Green M, Buzdar AU. Results from a prospective trial of neoadjuvant paclitaxel and doxorubicin for breast cancer. Presented at the American Society of Clinical Oncology 2002 Symposium. Orlando (FL), May 2002.
45. Smith I.C., Heys S.D., Hutcheon A.W., et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol 20 (2002) 1456-1466
46. Heys S.D., Hutcheon A.W., Sarkar T.K., et al. Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial. Clin Breast Cancer 2 3 Suppl (2002) S69-S74
47. Dixon J.M., Anderson T.J., and Miller W.R. Neoadjuvant endocrine therapy of breast cancer: a surgical perspective. Eur J Cancer 38 (2002) 2214-2221
48. Ellis M, Coop A, Singh B. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1 and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol 2001;19:3808-3816.
49. Pusztai L., Ayers M., Stec J., et al. Clinical application of cDNA microarrays in oncology. Oncologist 8 (2003) 252-258
50. Helvie M.A., Joynt L.K., Cody R.L., et al. Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. Radiology 198 (1996) 327-332
51. Delille J.P., Slanetz P.J., Yeh E.D., et al. Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology 228 (2003) 63-69
52. Abraham D., Jones R., Jones S., et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging. Cancer 78 (1996) 91-100
53. Wahl R., Zasadny K., and Helvie M. Metabolic monitoring of breast cancer chemohormonal therapy using positron emission tomography: initial evaluation. J Clin Oncol 11 (1993) 2101-2111
54. Mezi S., Primi F., Capoccetti F., et al. In vivo detection of resistance to anthracycline-based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography. Int J Oncol 22 (2003) 1233-1240
55. Wilczek B., von Schoultz E., Bergh J., et al. Early assessment of neoadjuvant chemotherapy by FEC courses of locally advanced breast cancer using 99mTc-MIBI. Acta Radiol 44 (2003) 284-287
56. Newman L.A., Kuerer H.M., Hunt K.K., et al. Feasibility of immediate breast reconstruction for locally advanced breast cancer. Ann Surg Oncol 6 (1999) 671-675
57. Styblo T., Lewis M., Carlson G., et al. Immediate breast reconstruction for stage III breast cancer using transverse rectus abdominis musculotaneous (TRAM) flap. Ann Surg Oncol 3 (1996) 375-380
58. Tran N.V., Chang D.W., Gupta A., et al. Comparison of immediate and delayed free TRAM flap breast reconstruction in patients receiving postmastectomy radiation therapy. Plast Reconstr Surg 108 (2001) 78-82
59. Mamounas E, Wang J, Bryant J, et al. Patterns of loco-regional failure in patients receiving neoadjuvant chemotherapy: results from NSABP B-18. Presented at the 26th Annual San Antonio Breast Cancer Symposium. San Antonio (TX), December 2003.
60. Buchholz T.A., Katz A., Strom E.A., et al. Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 53 (2002) 880-888
61. Bedrosian I., Reynolds C., Mick R., et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 88 (2000) 2540-2545
62. Chung M., Ye W., and Giuliano A. Role for sentinel lymph node dissection in the management of large (> or + 5 cm) invasive breast cancer. Ann Surg Oncol 8 (2001) 688-692
63. Breslin T.M., Cohen L., Sahin A., et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 18 (2000) 3480-3486
64. Nason K.S., Anderson B.O., Byrd D.R., et al. Increased false-negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 89 (2000) 2187-2194
65. Haid A., Tausch C., Lang A., et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma?. Cancer 92 (2001) 1080-1084
66. Fernandez A., Cortes M., Benito E., et al. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun 22 (2001) 361-366
67. Tafra L., Verbanac K., and Lannin D. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg 182 (2001) 312-315
68. Stearns V., Ewing C.A., Slack R., et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9 (2002) 235-242
69. Julian T.B., Dusi D., and Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 184 (2002) 315-317
70. Miller A.R., Thomason V.E., Yeh I.T., et al. Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol 9 (2002) 243-247
71. Brady E. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J 8 (2002) 97-100
72. Piato J., Barros A., Pincerato K., et al. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Oncol 29 (2002) 118-120
73. Balch G.C., Mithani S.K., Richards K.R., et al. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol 10 (2003) 616-621
74. Schwartz G.F., and Meltzer A.J. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 9 (2003) 374-379
75. Reitsamer R., Peintinger F., Rettenbacher L., et al. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol 84 (2003) 63-67
76. Mamounas E.P., Brown A., Anderson S., et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23 (2005) 2694-2702
77. Zirngibl C, Steinfeld-Birg D, Vogt H, et al. Sentinel lymph node biopsy before neoadjuvant chemotherapy- conservation of breast and axilla, abstract #516. San Antonio Breast Cancer Symposium. San Antonio, Texas; December 13, 2002.
78. Sabel M.S., Schott A.F., Kleer C.G., et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg 186 (2003) 102-105
79. Ollila D.W., Neuman H.B., Sartor C., et al. Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancers. Am J Surg 190 (2005) 371-375
80. Khan A., Sabel M.S., Nees A., et al. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy. Ann Surg Oncol 12 (2005) 697-704
81. Newman EA, Sabel M, Nees A, et al. Sentinel lymph node biopsy following neoadjuvant chemotherapy is Accurate in patients with documented nodal metastases at presentation. Ann Surg Onc, in press.
82. Piccart-Gebhart M.J., Procter M., Leyland-Jones B., et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353 (2005) 1659-1672
83. Romond E.H., Perez E.A., Bryant J., et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353 (2005) 1673-1684
84. Downey R., Rusch V., Hsu F., et al. Chest wall resection for locally recurrent breast cancer: is it worthwhile?. J Thorac Cardiovasc Surg 119 (2000) 420-428
85. Chagpar A., Meric-Bernstam F., Hunt K., et al. Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol 10 (2003) 628-634